JP2010115195A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010115195A5 JP2010115195A5 JP2009253394A JP2009253394A JP2010115195A5 JP 2010115195 A5 JP2010115195 A5 JP 2010115195A5 JP 2009253394 A JP2009253394 A JP 2009253394A JP 2009253394 A JP2009253394 A JP 2009253394A JP 2010115195 A5 JP2010115195 A5 JP 2010115195A5
- Authority
- JP
- Japan
- Prior art keywords
- mammal
- test sample
- immune response
- detecting
- tissue cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000124008 Mammalia Species 0.000 claims 24
- 210000001519 tissues Anatomy 0.000 claims 18
- 201000010099 disease Diseases 0.000 claims 10
- 230000028993 immune response Effects 0.000 claims 10
- 230000002757 inflammatory Effects 0.000 claims 10
- 229920001184 polypeptide Polymers 0.000 claims 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 102000004965 antibodies Human genes 0.000 claims 8
- 108090001123 antibodies Proteins 0.000 claims 8
- 230000015572 biosynthetic process Effects 0.000 claims 8
- 238000005755 formation reaction Methods 0.000 claims 8
- 230000021633 leukocyte mediated immunity Effects 0.000 claims 4
- 230000001404 mediated Effects 0.000 claims 4
- 206010021425 Immune system disease Diseases 0.000 claims 2
- 230000004044 response Effects 0.000 claims 2
Claims (14)
- 哺乳動物の免疫関連疾患の検出方法であって、(a)哺乳動物から採取した組織細胞の試験試料中、及び(b)同じ細胞型の既知の正常組織細胞のコントロール試料中における、配列番号1136に示すアミノ酸配列を有するポリペプチドをコードする遺伝子の発現レベルを検出することを含み、このときコントロール試料と比較して試験試料中における該遺伝子の発現レベルが高いか又は低いことにより、試験組織細胞が採取された哺乳動物における免疫関連疾患の存在が示される方法。
- 哺乳動物の免疫関連疾患の検出方法であって、(a)哺乳動物から採取した組織細胞の試験試料と、配列番号1136に示すアミノ酸配列に結合する抗体とを接触させることと、(b)抗体と試験試料中のポリペプチドとの間の複合体の形成を検出することを含み、このとき該複合体の形成により、試験組織細胞が採取された哺乳動物における免疫関連疾患の存在が示される方法。
- 免疫関連疾患がT細胞媒介性免疫疾患である、請求項1又は2に記載の方法。
- 哺乳動物の炎症性免疫反応の検出方法であって、(a)哺乳動物から採取した組織細胞の試験試料中、及び(b)同じ細胞型の既知の正常組織細胞のコントロール試料中における、配列番号1136に示すアミノ酸配列を有するポリペプチドをコードする遺伝子の発現レベルを検出することを含み、このときコントロール試料と比較して試験試料中における該遺伝子の発現レベルが高いか又は低いことにより、試験組織細胞が採取された哺乳動物における炎症性免疫反応の存在が示される方法。
- 哺乳動物の炎症性免疫反応の検出方法であって、(a)哺乳動物から採取した組織細胞の試験試料と、配列番号1136に示すアミノ酸配列に結合する抗体とを接触させることと、(b)抗体と試験試料中のポリペプチドとの間の複合体の形成を検出することを含み、このとき該複合体の形成により、試験組織細胞が採取された哺乳動物における炎症性免疫反応の存在が示される方法。
- 炎症性免疫反応がT細胞媒介性免疫反応である、請求項4又は5に記載の方法。
- T細胞媒介性免疫反応がCD45RO T細胞媒介性反応である、請求項6に記載の方法。
- 哺乳動物の免疫関連疾患を診断するためのキットであって、(a)哺乳動物から採取した組織細胞の試験試料中、及び(b)同じ細胞型の既知の正常組織細胞のコントロール試料中における、配列番号1136に示すアミノ酸配列を有するポリペプチドをコードする遺伝子の発現レベルを検出するための手段を具備し、このときコントロール試料と比較して試験試料中における該遺伝子の発現レベルが高いか又は低いことにより、試験組織細胞が採取された哺乳動物における免疫関連疾患の存在が示されるキット。
- 哺乳動物の免疫関連疾患を診断するためのキットであって、(a)哺乳動物から採取した組織細胞の試験試料と、配列番号1136に示すアミノ酸配列を有するポリペプチドに結合する抗体とを接触させるための手段と、(b)抗体と試験試料中のポリペプチドとの間の複合体の形成を検出するための手段とを具備し、このとき該複合体の形成により、試験組織細胞が採取された哺乳動物における免疫関連疾患の存在が示されるキット。
- 免疫関連疾患がT細胞媒介性免疫疾患である、請求項8又は9に記載のキット。
- 哺乳動物の炎症性免疫反応を診断するためのキットであって、(a)哺乳動物から採取した組織細胞の試験試料中、及び(b)同じ細胞型の既知の正常組織細胞のコントロール試料中における、配列番号1136に示すアミノ酸配列を有するポリペプチドをコードする遺伝子の発現レベルを検出するための手段を具備し、このときコントロール試料と比較して試験試料中における該遺伝子の発現レベルが高いか又は低いことにより、試験組織細胞が採取された哺乳動物における炎症性免疫反応の存在が示されるキット。
- 哺乳動物の炎症性免疫反応を診断するためのキットであって、(a)哺乳動物から採取した組織細胞の試験試料と、配列番号1136に示すアミノ酸配列を有するポリペプチドに結合する抗体とを接触させるための手段と、(b)抗体と試験試料中のポリペプチドとの間の複合体の形成を検出するための手段とを具備し、このとき該複合体の形成により、試験組織細胞が採取された哺乳動物における炎症性免疫反応の存在が示されるキット。
- 炎症性免疫反応がT細胞媒介性免疫反応である、請求項11又は12に記載のキット。
- T細胞媒介性免疫反応がCD45RO T細胞媒介性反応である、請求項13に記載のキット。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42247202P | 2002-10-29 | 2002-10-29 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004548574A Division JP2006517785A (ja) | 2002-10-29 | 2003-10-28 | 免疫関連疾患の治療のための新規組成物と方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012187148A Division JP2012254093A (ja) | 2002-10-29 | 2012-08-28 | 免疫関連疾患の治療のための新規組成物と方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010115195A JP2010115195A (ja) | 2010-05-27 |
JP2010115195A5 true JP2010115195A5 (ja) | 2011-04-14 |
Family
ID=32230357
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004548574A Pending JP2006517785A (ja) | 2002-10-29 | 2003-10-28 | 免疫関連疾患の治療のための新規組成物と方法 |
JP2009253394A Pending JP2010115195A (ja) | 2002-10-29 | 2009-11-04 | 免疫関連疾患の治療のための新規組成物と方法 |
JP2012187148A Pending JP2012254093A (ja) | 2002-10-29 | 2012-08-28 | 免疫関連疾患の治療のための新規組成物と方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004548574A Pending JP2006517785A (ja) | 2002-10-29 | 2003-10-28 | 免疫関連疾患の治療のための新規組成物と方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012187148A Pending JP2012254093A (ja) | 2002-10-29 | 2012-08-28 | 免疫関連疾患の治療のための新規組成物と方法 |
Country Status (6)
Country | Link |
---|---|
US (2) | US20070185017A1 (ja) |
EP (5) | EP2322200A3 (ja) |
JP (3) | JP2006517785A (ja) |
AU (2) | AU2003298607B9 (ja) |
CA (1) | CA2503330A1 (ja) |
WO (1) | WO2004039956A2 (ja) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7479555B2 (en) | 1999-07-21 | 2009-01-20 | Ceres, Inc. | Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity |
WO2005019258A2 (en) * | 2003-08-11 | 2005-03-03 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
DE602004019556D1 (de) * | 2003-10-30 | 2009-04-02 | Kazusa Dna Res Instutite Found | Neues plexin-polypeptid, dieses codierende dna und verwendung davon |
US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
WO2005106488A2 (en) * | 2004-04-28 | 2005-11-10 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g protein-coupled beta-2 adrenoceptor (adrb2) |
CA2501422C (en) | 2004-04-29 | 2014-08-12 | University Of Rochester | Lymphoid chemokines in the diagnosis, monitoring and treatment of autoimmune disease |
US7501121B2 (en) | 2004-06-17 | 2009-03-10 | Wyeth | IL-13 binding agents |
AR049390A1 (es) | 2004-06-09 | 2006-07-26 | Wyeth Corp | Anticuerpos contra la interleuquina-13 humana y usos de los mismos |
JP2006042802A (ja) * | 2004-06-28 | 2006-02-16 | Sumitomo Chemical Co Ltd | コモンマーモセット由来のヒポキサンチングアニンホスホリボシルトランスフェラーゼ遺伝子及びその利用 |
EA012799B1 (ru) | 2004-08-16 | 2009-12-30 | Кварк Фармасьютикалс, Инк. | Терапевтические применения ингибиторов rtp801 |
EP2527837A1 (en) | 2004-10-04 | 2012-11-28 | University of Washington | Methods of inhibiting cell death or inflammation in a mammal |
DE102004059781A1 (de) * | 2004-12-10 | 2006-06-22 | Sanofi-Aventis Deutschland Gmbh | Verwendung der Serum-/Glucocorticoid regulierten Kinase |
WO2006069000A2 (en) * | 2004-12-21 | 2006-06-29 | The Brigham And Women's Hospital, Inc. | Klf2 as a mediator of statin activity |
US7795503B2 (en) | 2005-02-22 | 2010-09-14 | Ceres, Inc. | Modulating plant alkaloids |
EP2343320B1 (en) | 2005-03-25 | 2017-10-25 | GITR, Inc. | Anti-gitr antibodies and uses thereof |
US8124839B2 (en) | 2005-06-08 | 2012-02-28 | Ceres, Inc. | Identification of terpenoid-biosynthesis related regulatory protein-regulatory region associations |
NL2000439C2 (nl) | 2006-01-20 | 2009-03-16 | Quark Biotech | Therapeutische toepassingen van inhibitoren van RTP801. |
WO2008054534A2 (en) * | 2006-05-11 | 2008-05-08 | Quark Pharmaceuticals, Inc. | Screening systems utilizing rtp801 |
WO2007141796A2 (en) * | 2006-06-09 | 2007-12-13 | Quark Pharmaceuticals, Inc. | Therapeutic uses of inhibitors of rtp801l |
US8343918B2 (en) | 2006-06-09 | 2013-01-01 | Novartis Ag | Stabilized insulin-like growth factor polypeptides |
EP2084296B1 (en) * | 2006-09-29 | 2015-08-05 | Agendia N.V. | High-throughput diagnostic testing using arrays |
WO2008065637A1 (en) * | 2006-12-01 | 2008-06-05 | University College York - National University Of Ireland, Cork | Treatment of disease |
US7705122B2 (en) * | 2006-12-04 | 2010-04-27 | Intrexon Corporation | mTOR ligands and polynucleotides encoding mTOR ligands |
MX2009006438A (es) * | 2006-12-19 | 2009-08-07 | Sanofi Aventis | Genes de exon unico que codifican nuevos peptidos bioactivos. |
US7872119B2 (en) | 2007-02-26 | 2011-01-18 | Quark Pharmaceuticals, Inc. | Inhibitors of RTP801 and their use in disease treatment |
ES2424976T3 (es) * | 2007-06-03 | 2013-10-10 | Oncotx, Inc. | Isoformas relativas al cáncer de componentes de complejos de factores de transcripción como biomarcadores y dianas de fármacos |
ES2591281T3 (es) * | 2007-07-12 | 2016-11-25 | Gitr, Inc. | Terapias de combinación que emplean moléculas de enlazamiento a GITR |
DE102007041657A1 (de) * | 2007-09-03 | 2009-03-05 | Protagen Ag | Markersequenzen für Multiple Sklerose und deren Verwendung |
US8614311B2 (en) | 2007-12-12 | 2013-12-24 | Quark Pharmaceuticals, Inc. | RTP801L siRNA compounds and methods of use thereof |
KR100983475B1 (ko) * | 2008-01-17 | 2010-09-24 | 고려대학교 산학협력단 | 당뇨병성 망막증 진단용 바이오마커 |
AR072999A1 (es) | 2008-08-11 | 2010-10-06 | Medarex Inc | Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos |
WO2010051502A2 (en) | 2008-10-31 | 2010-05-06 | Biogen Idec Ma Inc. | Light targeting molecules and uses thereof |
EP2362877A4 (en) * | 2008-11-06 | 2012-05-09 | Univ Columbia | POLYNUCLEOTIDES CODING FOR HUMAN TRIM-CYP FUSION POLYPEPTIDE, COMPOSITIONS THEREOF, AND METHOD OF USE THEREOF |
EP2373690B1 (en) | 2008-12-08 | 2015-02-11 | Compugen Ltd. | Antibodies specific for tmem154 |
PT2406284T (pt) | 2009-03-10 | 2016-09-29 | Biogen Ma Inc | Anticorpos anti-bcma |
WO2010141999A1 (en) * | 2009-06-12 | 2010-12-16 | The University Of Queensland | Agents and methods for diagnosing and treating ankylosing spondylitis |
AU2011248490B2 (en) * | 2010-04-29 | 2016-11-10 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases |
CN103096912A (zh) * | 2010-05-03 | 2013-05-08 | Atyr医药公司 | 与苯丙氨酰-α-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
WO2012031099A2 (en) | 2010-09-02 | 2012-03-08 | Vaccinex, Inc. | Anti-cxcl13 antibodies and methods of using the same |
US10273294B2 (en) | 2010-10-11 | 2019-04-30 | University Of Southern California | Compositions and methods for treating HIF-1α over-expressing cancers |
WO2012051207A2 (en) * | 2010-10-11 | 2012-04-19 | University Of Southern California | FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsup90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS |
AR087329A1 (es) | 2011-06-17 | 2014-03-19 | Regeneron Pharma | Anticuerpos humanos contra proteina 3 de tipo angiopoietina humana |
CA2841111A1 (en) | 2011-07-08 | 2013-01-17 | Novartis Ag | Novel pyrrolo pyrimidine derivatives |
US9522943B2 (en) | 2012-03-02 | 2016-12-20 | Rhode Island Hospital, A Lifespan-Partner | Treating human immunodeficiency virus infections |
EP2820045B1 (en) | 2012-03-02 | 2018-08-22 | Vaccinex, Inc. | Methods for the treatment of b cell-mediated inflammatory diseases |
AU2013234046B2 (en) * | 2012-03-16 | 2017-09-07 | University Health Network | Methods and compositions for modulating Toso activity |
UY34887A (es) | 2012-07-02 | 2013-12-31 | Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware | Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos |
WO2014093417A1 (en) * | 2012-12-12 | 2014-06-19 | University Of Virginia Patent Foundation | Compositions and methods for regulating erythropoiesis |
CN105408355A (zh) | 2013-01-31 | 2016-03-16 | 瓦克纳斯有限公司 | 用于提高免疫球蛋白a水平的方法 |
JP6205175B2 (ja) * | 2013-05-16 | 2017-10-04 | 株式会社Resvo | 精神・神経疾患バイオマーカー |
HUE044730T2 (hu) | 2013-09-20 | 2019-11-28 | Bristol Myers Squibb Co | Anti-LAG-3 antitestek és Anti-PD-1 antitestek kombinációja tumorok kezelésére |
US9512084B2 (en) | 2013-11-29 | 2016-12-06 | Novartis Ag | Amino pyrimidine derivatives |
JOP20200094A1 (ar) | 2014-01-24 | 2017-06-16 | Dana Farber Cancer Inst Inc | جزيئات جسم مضاد لـ pd-1 واستخداماتها |
TWI777174B (zh) | 2014-03-14 | 2022-09-11 | 瑞士商諾華公司 | 針對lag-3之抗體分子及其用途 |
WO2015187835A2 (en) | 2014-06-06 | 2015-12-10 | Bristol-Myers Squibb Company | Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof |
MA41414A (fr) | 2015-01-28 | 2017-12-05 | Centre Nat Rech Scient | Protéines de liaison agonistes d' icos |
US20160310567A1 (en) * | 2015-04-23 | 2016-10-27 | Florida Atlantic University | Compositions for inhibiting viral replication and methods of use and production thereof |
CN107743586B (zh) | 2015-06-03 | 2021-07-02 | 百时美施贵宝公司 | 用于癌症诊断的抗gitr抗体 |
US11391744B2 (en) | 2015-06-08 | 2022-07-19 | Arquer Diagnostic Limited | Methods and kits |
ES2806498T3 (es) | 2015-06-08 | 2021-02-17 | Arquer Diagnostics Ltd | Métodos para el análisis de una muestra de orina |
CA3005855A1 (en) | 2015-11-19 | 2017-05-26 | Bristol-Myers Squibb Company | Antibodies against glucocorticoid-induced tumor necrosis factor receptor (gitr) and uses thereof |
US11400142B2 (en) * | 2015-12-18 | 2022-08-02 | Talengen International Limited | Treatment of diabetic nerve injury comprising administering plasminogen |
EP3395354B1 (en) * | 2015-12-18 | 2024-05-22 | Talengen International Limited | Plasminogen for use in treating diabetic nephropathy |
EP3556384B1 (en) | 2016-12-15 | 2024-04-10 | Talengen International Limited | Plasminogen for use in treating diabetes |
BR112019015797A2 (pt) | 2017-02-01 | 2020-03-17 | Modernatx, Inc. | Composições de mrna terapêuticas imunomoduladoras que codificam peptídeos de mutação de oncogene de ativação |
US11623945B2 (en) | 2017-02-06 | 2023-04-11 | The United States Of America, As Represented By The Secretary Of Agriculture | Immunostimulating compositions and uses therefore |
KR20200006115A (ko) | 2017-05-16 | 2020-01-17 | 브리스톨-마이어스 스큅 컴퍼니 | 항-gitr 효능제 항체에 의한 암의 치료 |
CN110678200B (zh) | 2017-05-30 | 2024-05-17 | 百时美施贵宝公司 | 包含抗lag-3抗体或抗lag-3抗体和抗pd-1或抗pd-l1抗体的组合物 |
BR112019020610A2 (pt) | 2017-05-30 | 2020-04-22 | Bristol-Myers Squibb Company | tratamento de tumores positivos para o lag-3 |
WO2019153029A1 (en) * | 2018-02-06 | 2019-08-15 | Meat & Livestock Australia Limited | Polypeptide, compositions and uses thereof |
Family Cites Families (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4943529A (en) | 1982-05-19 | 1990-07-24 | Gist-Brocades Nv | Kluyveromyces as a host strain |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
AU2353384A (en) | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4675187A (en) | 1983-05-16 | 1987-06-23 | Bristol-Myers Company | BBM-1675, a new antibiotic complex |
DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
AU3145184A (en) | 1983-08-16 | 1985-02-21 | Zymogenetics Inc. | High expression of foreign genes in schizosaccharomyces pombe |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4736866B1 (en) | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
DE3675588D1 (de) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist. |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
JPS63502716A (ja) | 1986-03-07 | 1988-10-13 | マサチューセッツ・インステチュート・オブ・テクノロジー | 糖タンパク安定性の強化方法 |
GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
US4946783A (en) | 1987-01-30 | 1990-08-07 | President And Fellows Of Harvard College | Periplasmic protease mutants of Escherichia coli |
US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
WO1989005859A1 (en) | 1987-12-21 | 1989-06-29 | The Upjohn Company | Agrobacterium mediated transformation of germinating plant seeds |
AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
DE394538T1 (de) | 1989-04-28 | 1991-04-11 | Rhein Biotech Ges. Fuer Biotechnologische Prozesse Und Produkte Mbh, 4000 Duesseldorf, De | Hefezellen der schwanniomyces-gattung. |
EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
ES2096590T3 (es) | 1989-06-29 | 1997-03-16 | Medarex Inc | Reactivos biespecificos para la terapia del sida. |
FR2649120B1 (fr) | 1989-06-30 | 1994-01-28 | Cayla | Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
EP0546073B1 (en) | 1990-08-29 | 1997-09-10 | GenPharm International, Inc. | production and use of transgenic non-human animals capable of producing heterologous antibodies |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
CA2102511A1 (en) | 1991-05-14 | 1992-11-15 | Paul J. Higgins | Heteroconjugate antibodies for treatment of hiv infection |
WO1993005169A1 (en) * | 1991-08-30 | 1993-03-18 | Fred Hutchinson Cancer Research Center | Hybrid cytokines |
WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
AU3178993A (en) | 1991-11-25 | 1993-06-28 | Enzon, Inc. | Multivalent antigen-binding proteins |
DK0669836T3 (da) | 1992-11-13 | 1996-10-14 | Idec Pharma Corp | Terapeutisk anvendelse af kimære og radioaktivt mærkede antistoffer og humant B-lymfocytbegrænset differentieringsantigen til behandling af B-cellelymfom |
PT616812E (pt) | 1993-03-24 | 2000-04-28 | Berlex Biosciences | Combinacao de compostos anti-hormonais e moleculas de ligacao no tratamento do cancro |
US6562333B1 (en) * | 1993-06-14 | 2003-05-13 | Schering Corporation | Purified mammalian CTLA-8 antigens and related reagents |
US6274711B1 (en) * | 1993-06-14 | 2001-08-14 | Inserm, Institut National De La Sante Et De La Recherche Medicale | Purified mammalian CTLA-8 antigens and related reagents |
US6326469B1 (en) * | 1994-04-22 | 2001-12-04 | Sugen, Inc. | Megakaryocytic protein tyrosine kinases |
US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
US5869286A (en) * | 1995-03-23 | 1999-02-09 | Immunex Corporation | Receptor that binds IL-17 |
AU2582897A (en) | 1996-03-15 | 1997-10-01 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation |
US6479254B2 (en) * | 1996-03-22 | 2002-11-12 | Human Genome Sciences, Inc. | Apoptosis inducing molecule II |
US5861308A (en) * | 1996-08-21 | 1999-01-19 | Ludwig Institute For Cancer Research | Isolated nucleic acids associated with T cell activation and uses thereof |
JP2002511732A (ja) * | 1996-10-11 | 2002-04-16 | ザ・テキサス・エイ・アンド・エム・ユニヴァーシティ・システム | トランスジェニック動物を発生させるための組成物および方法 |
US6183951B1 (en) * | 1997-04-11 | 2001-02-06 | Prometheus Laboratories, Inc. | Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-Th1 cytokine therapy |
AU764441B2 (en) * | 1998-02-09 | 2003-08-21 | Genset S.A. | cDNAs encoding secreted proteins |
EP1220905A2 (en) * | 1999-03-08 | 2002-07-10 | Genentech Inc. | Composition and methods for the treatment of immune related diseases |
AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
WO2000064479A1 (en) * | 1999-04-27 | 2000-11-02 | Antibody Systems, Inc. | Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders |
EP1074617A3 (en) * | 1999-07-29 | 2004-04-21 | Research Association for Biotechnology | Primers for synthesising full-length cDNA and their use |
JP2002191363A (ja) * | 1999-07-29 | 2002-07-09 | Herikkusu Kenkyusho:Kk | 全長cDNA合成用プライマー、およびその用途 |
AU2001241541A1 (en) * | 2000-02-17 | 2001-08-27 | Millennium Predictive Medicine, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer |
GB0005345D0 (en) * | 2000-03-06 | 2000-04-26 | Mathilda & Terence Kennedy Ins | Methods of treating sepsis septic shock and inflammation |
HUP0303656A3 (en) * | 2000-10-23 | 2006-03-28 | Bristol Myers Squibb Co | Modulators of bruton's tyrosine kinase, their identification and use |
WO2002068579A2 (en) * | 2001-01-10 | 2002-09-06 | Pe Corporation (Ny) | Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof |
WO2002064739A2 (en) * | 2001-02-09 | 2002-08-22 | Johns Hopkins University | A cytokine related structurally to il-17 |
GB0105402D0 (en) * | 2001-03-05 | 2001-04-18 | Inpharmatica Ltd | Novel proteins |
US20040101874A1 (en) * | 2002-04-12 | 2004-05-27 | Mitokor Inc. | Targets for therapeutic intervention identified in the mitochondrial proteome |
-
2003
- 2003-10-28 EP EP10195510A patent/EP2322200A3/en not_active Ceased
- 2003-10-28 EP EP10195513A patent/EP2322202A3/en not_active Ceased
- 2003-10-28 US US10/533,069 patent/US20070185017A1/en not_active Abandoned
- 2003-10-28 EP EP10195512A patent/EP2322201A3/en not_active Ceased
- 2003-10-28 EP EP03796358A patent/EP1576137A4/en not_active Withdrawn
- 2003-10-28 EP EP10195515A patent/EP2322203A3/en not_active Ceased
- 2003-10-28 AU AU2003298607A patent/AU2003298607B9/en not_active Ceased
- 2003-10-28 WO PCT/US2003/034381 patent/WO2004039956A2/en active Application Filing
- 2003-10-28 CA CA002503330A patent/CA2503330A1/en not_active Abandoned
- 2003-10-28 JP JP2004548574A patent/JP2006517785A/ja active Pending
-
2009
- 2009-11-04 JP JP2009253394A patent/JP2010115195A/ja active Pending
- 2009-12-24 AU AU2009251206A patent/AU2009251206B2/en not_active Ceased
-
2011
- 2011-02-23 US US13/033,177 patent/US20110245096A1/en not_active Abandoned
-
2012
- 2012-08-28 JP JP2012187148A patent/JP2012254093A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010115195A5 (ja) | ||
JP2010207229A5 (ja) | ||
JP2012115275A5 (ja) | ||
JP2011050389A5 (ja) | ||
JP2011512817A5 (ja) | ||
JP2013516633A5 (ja) | ||
JP2010220614A5 (ja) | ||
JP2012509295A5 (ja) | ||
JP2006516094A5 (ja) | ||
JP2010521655A5 (ja) | ||
RU2009135270A (ru) | Способы выявления воспалительного заболевания кишечника | |
SI2524060T1 (en) | Investigation for JC virus antibodies | |
RU2009126617A (ru) | Собачий тимусный стромальный лимфопоэтический белок и его применение | |
EP3455371A1 (en) | Tissue-specific exosomes as biomarkers | |
JP2013539032A5 (ja) | ||
Bilić et al. | Serum proteome profiling in canine idiopathic dilated cardiomyopathy using TMT-based quantitative proteomics approach | |
NZ598035A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
RU2019103403A (ru) | Адреномедуллин для оценки застоя у индивидуума с острой сердечной недостаточностью | |
Bourgonje et al. | Phage-display immunoprecipitation sequencing of the antibody epitope repertoire in inflammatory bowel disease reveals distinct antibody signatures | |
JP2011518338A5 (ja) | ||
JP2014524583A5 (ja) | ||
CN111596070B (zh) | 一种三疣梭子蟹原肌球蛋白过敏检测试剂的应用 | |
JP2014501929A5 (ja) | ||
JP2011513759A5 (ja) | ||
JP2007525213A5 (ja) |